BOOSTRIX POLIO SUSPENSION FOR INJECTION
Product details
Registration number: SIN15888P
Classification: Prescription Only
Active ingredients:
- Diphtheria toxoid
- Filamentous Hemagglutinin (FHA)
- Inactivated polio virus type 1
- Inactivated polio virus type 2
- Inactivated polio virus type 3
- Pertactin (PRN)
- Pertussis toxoid (PT)
- Tetanus toxoid
Strength:
- 2.5 Lf/ 0.5 ml - not less than 2 IU
- 8 mcg/0.5ml
- 40 DU/0.5 ml
- 8 DU/0.5 ml
- 32 DU/0.5 ml
- 2.5 mcg/0.5 ml
- 8 mcg/0.5 ml
- 5.0 Lf/0.5ml - not less than 20 IU
Dosage form: INJECTION, SUSPENSION
Route: INTRAMUSCULAR
Registrant: GLAXOSMITHKLINE PTE LTD
ATC code: J07CA02
HSA approval date: 20 February 2020
Manufacturer(s): GlaxoSmithKline Biologicals SAS
Manufacturing country/countries: FRANCE
What are the HSA registration number and classification for BOOSTRIX POLIO SUSPENSION FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15888P
Classification: Prescription Only
What active ingredients and strength are recorded for BOOSTRIX POLIO SUSPENSION FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Diphtheria toxoid
- Filamentous Hemagglutinin (FHA)
- Inactivated polio virus type 1
- Inactivated polio virus type 2
- Inactivated polio virus type 3
- Pertactin (PRN)
- Pertussis toxoid (PT)
- Tetanus toxoid
Strength:
- 2.5 Lf/ 0.5 ml - not less than 2 IU
- 8 mcg/0.5ml
- 40 DU/0.5 ml
- 8 DU/0.5 ml
- 32 DU/0.5 ml
- 2.5 mcg/0.5 ml
- 8 mcg/0.5 ml
- 5.0 Lf/0.5ml - not less than 20 IU
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for BOOSTRIX POLIO SUSPENSION FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SUSPENSION
Route: INTRAMUSCULAR
Who is the recorded registrant for BOOSTRIX POLIO SUSPENSION FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Registrant: GLAXOSMITHKLINE PTE LTD
Which manufacturers and countries are listed for BOOSTRIX POLIO SUSPENSION FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): GlaxoSmithKline Biologicals SAS
Manufacturing country/countries: FRANCE
Where can I look up BOOSTRIX POLIO SUSPENSION FOR INJECTION in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15888P or the exact product name BOOSTRIX POLIO SUSPENSION FOR INJECTION. The general register link does not preselect this product.
What are the source dates for this BOOSTRIX POLIO SUSPENSION FOR INJECTION record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this BOOSTRIX POLIO SUSPENSION FOR INJECTION record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15888P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)